Internal Medicine, Rheumatology · Edina, MN
NPI
1790838753
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7600 France Ave S Ste 5100
Edina, MN, 55435
Phone (952) 893-1959
Groups this clinician bills Medicare through
Medicare paid, 2024
$948K
58,995 services
Medicare patients, 2024
396
Average age 73
Drug cost, 2024
$1.3M
3,360 prescriptions
Company payments, 2025
$64.44
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hammad A Bajwa was code J3262 (injection, tocilizumab, 1 mg), 20,720 times for 12 patients. In total Hammad A Bajwa billed 58,995 services in 55 codes, and Medicare paid $948K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 20,720 | 12 | $4.70 | $97K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,800 | 33 | $9.01 | $88K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,700 | 33 | $33.87 | $329K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,400 | 64 | $24.76 | $208K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 796 | 19 | $0.22 | $175 |
| 36415 Venipuncture Blood Collection | Office | 636 | 268 | $8.61 | $5,479 |
| 82565 Clinical Chemistry | Office | 599 | 252 | $5.01 | $2,998 |
| 84460 Clinical Chemistry | Office | 596 | 251 | $5.18 | $3,084 |
| 84450 Clinical Chemistry | Office | 596 | 251 | $5.07 | $3,019 |
| 82040 Clinical Chemistry | Office | 595 | 251 | $4.84 | $2,877 |
| 85027 Blood Count | Office | 497 | 227 | $6.33 | $3,146 |
| 99214 Office E&M - Established | Office | 491 | 226 | $88.68 | $44K |
| 96413 Chemotherapy Administration | Office | 434 | 155 | $102.88 | $45K |
| 86140 Clinical Chemistry | Office | 322 | 155 | $5.05 | $1,627 |
| 85652 Clinical Chemistry | Office | 305 | 149 | $2.64 | $804 |
By year: 2022 $834K for 36,428 services; 2023 $858K for 41,291 services; 2024 $948K for 58,995 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 636 | 268 | $8.61 | $5,479 |
| 82565 Clinical Chemistry | 599 | 252 | $5.01 | $2,998 |
| 84450 Clinical Chemistry | 596 | 251 | $5.07 | $3,019 |
| 84460 Clinical Chemistry | 596 | 251 | $5.18 | $3,084 |
| 82040 Clinical Chemistry | 595 | 251 | $4.84 | $2,877 |
| 85027 Blood Count | 497 | 227 | $6.33 | $3,146 |
| 86140 Clinical Chemistry | 322 | 155 | $5.05 | $1,627 |
| 85652 Clinical Chemistry | 305 | 149 | $2.64 | $804 |
| 85025 Blood Count | 85 | 66 | $7.46 | $634 |
| 86235 Immunoassay | 78 | 11 | $16.29 | $1,270 |
Medicare prescription drug claims, 2024
In 2024, the drug Hammad A Bajwa prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 828 prescriptions and refills. In total Hammad A Bajwa wrote 3,360 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 828 | 2,059 | 230 | $27K |
| Prednisone Generic | 725 | 1,716 | 225 | $7,055 |
| Hydroxychloroquine Sulfate Generic | 569 | 1,542 | 172 | $27K |
| Leflunomide Generic | 259 | 669 | 74 | $20K |
| Sulfasalazine Dr Sulfasalazine | 183 | 470 | 55 | $12K |
| Allopurinol Generic | 135 | 387 | 38 | $1,433 |
| Sulfasalazine Generic | 126 | 321 | 36 | $6,592 |
| Folic Acid Generic | 76 | 214 | 21 | $1,130 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 49 | 89 | 14 | $888 |
| Humira(Cf) Pen Adalimumab | 46 | 55 | Under 11 | $392K |
| Mycophenolate Mofetil Generic | 46 | 112 | 13 | $7,887 |
| Azathioprine Generic | 42 | 99 | Under 11 | $1,434 |
| Febuxostat Generic | 28 | 75 | Under 11 | $4,488 |
| Humira Pen Adalimumab | 26 | 30 | Under 11 | $201K |
| Diclofenac Sodium Generic | 23 | 63 | Under 11 | $640 |
Brand drugs: - claims; generic drugs: 2,796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hammad A Bajwa $64.44 ($64.44 in general payments such as food, travel and fees) from 2 companies. The largest payer was Fresenius Kabi USA, LLC with $36.02.
| Company | Payments | Amount |
|---|---|---|
| Fresenius Kabi USA, LLC | 1 | $36.02 |
| Organon LLC OGN | 1 | $28.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.